Ironwood Pharmaceuticals (IRWD) Share-based Compensation (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Share-based Compensation across 17 years of filings, most recently posting $303000.0 for Q2 2026.

• In Q2 2026, Share-based Compensation rose 244.32% year-over-year to $303000.0; the TTM figure through Jun 2026 stood at $7.8 million (down 40.1% YoY), while the FY2025 annual figure was $17.2 million, down 42.21% from the prior year.
• Share-based Compensation came in at $303000.0 for Q2 2026 at Ironwood Pharmaceuticals, down from $3.7 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $10.1 million in Q1 2024 to a low of $1000.0 in Q3 2025.
• Average Share-based Compensation over 5 years is $3.2 million, with a median of $1.6 million recorded in 2022.
• Year-over-year, Share-based Compensation jumped 63969.23% in 2024 and plunged 99.99% in 2025.
• Over 5 years, Share-based Compensation stood at $7.3 million in 2022, then advanced by 19.38% to $8.7 million in 2023, then tumbled by 47.54% to $4.6 million in 2024, then declined by 16.27% to $3.8 million in 2025, then tumbled by 92.07% to $303000.0 in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $303000.0 in Q2 2026, $3.7 million in Q1 2026, and $3.8 million in Q4 2025.